{"id":"NCT00286468","sponsor":"Takeda","briefTitle":"Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) When Used in Combination With a Sulfonylurea in Subjects With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-04","primaryCompletion":"2007-06","completion":"2007-06","firstPosted":"2006-02-03","resultsPosted":"2011-08-25","lastUpdate":"2012-02-03"},"enrollment":500,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Alogliptin and glyburide","otherNames":["alogliptin","SYR110322","SYR-322"]},{"type":"DRUG","name":"Alogliptin and glyburide","otherNames":["alogliptin","SYR110322","SYR-322"]},{"type":"DRUG","name":"Glyburide","otherNames":[]}],"arms":[{"label":"Alogliptin 12.5 mg QD","type":"EXPERIMENTAL"},{"label":"Alogliptin 25 mg QD","type":"EXPERIMENTAL"},{"label":"Placebo","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), combined with a sulfonylurea in adults with type 2 diabetes mellitus.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 26.","timeFrame":"Baseline and Week 26.","effectByArm":[{"arm":"Placebo","deltaMin":0.01,"sd":0.084},{"arm":"Alogliptin 12.5 mg QD","deltaMin":-0.38,"sd":0.058},{"arm":"Alogliptin 25 mg QD","deltaMin":-0.52,"sd":0.058}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":16,"exclusionCount":14},"locations":{"siteCount":68,"countries":["United States","Argentina","Australia","Brazil","Chile","Dominican Republic","Guatemala","India","Mexico","Netherlands","New Zealand","Peru","Poland","South Africa","United Kingdom"]},"refs":{"pmids":["19125778","19793357"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":99},"commonTop":["Urinary tract infection","Hypertension","Headache","Hypertriglyceridaemia","Nasopharyngitis"]}}